(Q36579480)

15 August 2017

1 reference

title

Pharmacological treatment of chronic heart failure (English)

1 reference

15 August 2017

1 reference

chronic heart failure

1 reference

4

Mihai Gheorghiade

1 reference

15 August 2017

Rachele Adorisio

1

1 reference

PubMed ID

16937030

15 August 2017

Leonardo De Luca

series ordinal

2

1 reference

PubMed ID

16937030

15 August 2017

Joseph Rossi

series ordinal

3

1 reference

15 August 2017

1 June 2006

1 reference

15 August 2017

Heart Failure Reviews

1 reference

15 August 2017

11

1 reference

15 August 2017

109-123

1 reference

15 August 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1007/s10741-006-9482-z

15 August 2017

0 references

cites work

Mechanisms and models in heart failure: A combinatorial approach

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Chronic heart failure in the United States: a manifestation of coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Alpha 1b-adrenoceptors mediate renal tubular sodium and water reabsorption in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Angiotensin II type 1 receptor blockers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Digoxin. A neurohormonal modulator in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

A prospective, randomized, double-blind, crossover study to compare the efficacy and safety of chronic nifedipine therapy with that of isosorbide dinitrate and their combination in the treatment of chronic congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Diltiazem increases late-onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Fat-suppressed breath-hold magnetic resonance coronary angiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10741-006-9482-Z

Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure

21 January 2018

1 reference

12 December 2020

Prolonged impairment of regional contractile function after resolution of exercise-induced angina. Evidence of myocardial stunning in patients with coronary artery disease

1 reference

12 December 2020

Differential effects of angiotensin converting enzyme inhibitors on the vasodepressor and prostacyclin responses to bradykinin

1 reference

12 December 2020

Aldosterone in Congestive Heart Failure: Analysis of Determinants and Role in Sodium Retention

1 reference

12 December 2020

Clinical practice. Diastolic heart failure

1 reference

12 December 2020

Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group

1 reference

12 December 2020

Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure: results of the Initiation Management Predischarge: Process for Assessment of Carvedilol Therapy in Heart Failure (IMPACT-HF) trial

1 reference

12 December 2020

The Effect of the Angiotensin-Converting–Enzyme Inhibitor Zofenopril on Mortality and Morbidity after Anterior Myocardial Infarction

1 reference

12 December 2020

Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy.

1 reference

12 December 2020

A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure

1 reference

12 December 2020

Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both

1 reference

12 December 2020

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

12 December 2020

Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators

1 reference

12 December 2020

Actin mutations in dilated cardiomyopathy, a heritable form of heart failure

1 reference

12 December 2020

The Ile164 beta2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure

1 reference

12 December 2020

Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis

1 reference

12 December 2020

Apoptotic cell death in heart failure

1 reference

12 December 2020

Digoxin for chronic heart failure: a review of the randomized controlled trials with special attention to the PROVED (Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin) and RADIANCE (Randomized Assessment of Digoxin on

1 reference

12 December 2020

Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)

1 reference

12 December 2020

Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD).

1 reference

12 December 2020

Effects of metoprolol CR in patients with ischemic and dilated cardiomyopathy : the randomized evaluation of strategies for left ventricular dysfunction pilot study

1 reference

12 December 2020

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

1 reference

12 December 2020

Synergistic polymorphisms of beta1- and alpha2C-adrenergic receptors and the risk of congestive heart failure

1 reference

12 December 2020

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dilatation in patients with asymptomatic systolic dysfunction. SOLVD (Studies of Left Ventricular Dysfunction) Investigators

1 reference

12 December 2020

Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy

1 reference

12 December 2020

Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients

1 reference

12 December 2020

Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure

1 reference

12 December 2020

Hemodynamic effects of captopril in patients with severe chronic heart failure

1 reference

12 December 2020

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

1 reference

12 December 2020

Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group.

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial

1 reference

12 December 2020

Hemodynamic and volumetric effects of venodilation with nitroglycerin in chronic mitral regurgitation

1 reference

12 December 2020

Inflammatory mediators in chronic heart failure: an overview

1 reference

12 December 2020

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

12 December 2020

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan

1 reference

12 December 2020

Concurrent hydralazine administration prevents nitroglycerin-induced hemodynamic tolerance in experimental heart failure

1 reference

12 December 2020

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

1 reference

12 December 2020

Myocardial Na,K-ATPase: the molecular basis for the hemodynamic effect of digoxin therapy in congestive heart failure

1 reference

12 December 2020

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

12 December 2020

Congestive heart failure: fifty years of progress

1 reference

12 December 2020

Effects of digoxin on morbidity and mortality in diastolic heart failure: the ancillary digitalis investigation group trial

1 reference

12 December 2020

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

12 December 2020

Enalapril: A new angiotensin-converting enzyme inhibitor in chronic heart failure: Acute and chronic hemodynamic evaluations

1 reference

12 December 2020

Both beta 1- and beta 2-adrenoceptors mediate catecholamine-evoked arrhythmias in isolated human right atrium

1 reference

12 December 2020

Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics

1 reference

12 December 2020

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

12 December 2020

Pathophysiology of chronic heart failure

1 reference

12 December 2020

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

12 December 2020

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

12 December 2020

Effect of prolonged nitrate therapy on left ventricular remodeling after canine acute myocardial infarction

1 reference

12 December 2020

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

12 December 2020

Combination of isosorbide dinitrate and hydralazine in blacks with heart failure

1 reference

12 December 2020

Importance of neuroendocrine activation in chronic heart failure. Impact on treatment strategies

1 reference

12 December 2020

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

1 reference

12 December 2020

Torasemide in chronic heart failure: results of the TORIC study

1 reference

12 December 2020

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial

1 reference

12 December 2020

Digitalis Investigation Group (DIG) trial: a stimulus for further research

1 reference

12 December 2020

Chronic AT1 receptor blockade and angiotensin-converting enzyme (ACE) inhibition in (CHF 146) cardiomyopathic hamsters: effects on cardiac hypertrophy and survival

1 reference

12 December 2020

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

1 reference

12 December 2020

1 reference

12 December 2020

ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Gu

1 reference

12 December 2020

The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial

1 reference

12 December 2020

Incidence of thromboembolic events in congestive heart failure. The V-HeFT VA Cooperative Studies Group

1 reference

12 December 2020

Current role of beta-adrenergic blockers in the management of chronic heart failure

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial

1 reference

12 December 2020

Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?

1 reference

12 December 2020

Randomised trial of effect of amiodarone on mortality in patients with left-ventricular dysfunction after recent myocardial infarction: EMIAT. European Myocardial Infarct Amiodarone Trial Investigators

1 reference

12 December 2020

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

12 December 2020

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

12 December 2020

Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction. The SWORD Investigators. Survival With Oral d-Sotalol.

1 reference

12 December 2020

Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure

1 reference

12 December 2020

Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)

1 reference

12 December 2020

The alpha 1A-adrenergic receptor subtype mediates biochemical, molecular, and morphologic features of cultured myocardial cell hypertrophy

1 reference

12 December 2020

Heart failure and the aging population: an increasing burden in the 21st century?

1 reference

12 December 2020

Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study

1 reference

12 December 2020

1 reference

12 December 2020

Investigation of alpha1-adrenoceptor subtypes mediating vasoconstriction in rabbit cutaneous resistance arteries.

1 reference

12 December 2020

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

12 December 2020

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

12 December 2020

Metoprolol controlled release/extended release in patients with severe heart failure: analysis of the experience in the MERIT-HF study

1 reference

12 December 2020

Association of serum digoxin concentration and outcomes in patients with heart failure

1 reference

12 December 2020

Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial

1 reference

12 December 2020

Effect of carvedilol on survival in severe chronic heart failure

1 reference

12 December 2020

Pharmacology of diuretics

1 reference

12 December 2020

A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure

1 reference

12 December 2020

Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

1 reference

12 December 2020

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

12 December 2020

Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

12 December 2020

Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

The hibernating myocardium: implications for management of congestive heart failure

1 reference

12 December 2020

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

12 December 2020

Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure

1 reference

12 December 2020

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

12 December 2020

Influence of isoproterenol on myocardial energetics. Experimental and clinical investigations

1 reference

12 December 2020

10.1007/S10741-006-9482-Z

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16937030